Blog

Is Enterosgel Antifungal?

Enterosgel Antifungul registration

Not every countries registered Enterosgel with antifungul claims on a Patiaent Information Leaflet (PIL). The Australian registration does not contain information about Enterosgel Antifungal action. Official registration is long process and in many cases companies are registered Enterosgel with minimum claims to avoid a long period marketing lostage. Despite the fact that Enterosgel has more than 420 successful scientific researchers in various fields of medicine, Enterosgel in many cases is still in the gray area between a medical device and a medicine. In 2023, in accordance with regulation 89(3) of the National  Health Service (NHS) regulations 2013, the Secretary of State for Health as respects England and in accordance with regulation 41(4) of the NHS Wales Regulations 2013, as respects Wales have amended the Drug Tariff and determinations made in respect of the amendments to the Drug Tariff included Enterosgel to the pharmaceutical remuneration list for advanced services.*

*Preface Amendments to the Drug tariff, July 2023 

Practitioners about Enterosgel

“I have a practitioner enquiry regarding the use of Enterosgel in Mycoplasma infection. A practitioner I see is treating a stubborn reoccurring Urinary Tract Infection caused by mycoplasma. As the size of Mycoplasma are extremely small, would Enterosgel have an affinity to bind and remove bacteria of this size? (jan19).

Refer to the study Rudenko Microorganisms ” The object of the study included reference strains of microorganisms – Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa, Staphylococcus aureus, Mycoplasma hominis, Ureaplasma urealyticum, Candida albicans – as well as strains isolated from patients. using enterosgel. studying the sorption properties of Enterosgel enterosorbent in relation to various types of opportunistic and pathogenic microorganisms, it was found that at hour 6 of the incubation they were completely adsorbed by Enterosgel (refer to study for more information).

Enterosgel is used in the treatment of candidiasis (e.g. oral cavity, GIT). It has been experimentally proven that it binds Candida from the medium (Nitsak, see the abstract below), this is not a fungicidal action in the classical sense of the term. It also helps to avoid side effects of antimicrobial preparations. There are clinical data supporting efficient using Enterosgel for the treatment of candidiasis, including in children (Malanicheva).

In 2008, the Ukranian research group Nitasak was conducted and published DETERMINATION OF SORPTION CAPACITY OF ORGANOSILICON INTESTINAL ADSORBENTS FOR BACTERIA

Abstract. The sorption capacity of organosilicon intestinal adsorbents for bacteria was studied. Silix and nanodispersed silica suspension demonstrated high sorption capacity for all test cultures, especially for P. vulgaris and C. albicans (above 90%).

In 2013, the Malanicheva research group published the research “Entero-absorption in treatment of children suffering from atopic dermatitis, complicated by fungus infection”.  Patients with atopic dermatitis (AD) are highly susceptible to certain cutaneous bacterial, fungal and viral infections. This study showed the effectiveness of the modern intestinal adsorbent (enterosorbent) Enterosgel in 40 children with complicated types of fungal skin infections. The overall therapeutic efficacy was 87.5% in the children receiving Enterosgel. This was manifested by a 1.8-fold decrease of the period of exacerbation (from 26 to 14 days) and a 4.5-fold decrease in the SCORAD index (from 54 to 12). Moreover, during the treatment, there was a threefold increase in the duration of remission (from 3.2 to 9.6 months). The number of exacerbations during the year dropped 3.3-fold (from 4 to 1.2). The total IgE level decreased almost threefold (from 350 to 120 IU/ml), IgE specific antibodies for whole cow’s milk proteins and casein – twofold, to chicken egg white – threefold. Consequently, the use of the intestinal adsorbent Enterosgel in the treatment
of AD aggravated by fungal infection leads to positive results amid a decrease in the level of sensitization and circulating Candida antigen in the blood serum.

Enterosgel in Helicobacter

Enterosgel Helicobacter


Please rate this information
  • 4/5
  • 1 rating
1 ratingX
Very bad! Bad Hmmm Oke Good!
0% 0% 0% 100% 0%
Read More

Medsilica-Promobot Artificial Intelligent Robots

New Zealand welcomes Artificial Intelligent Robots

The Medsilica Group is the first company in the Pacific Region to employ Artificial Intelligent Robots.

According to Dr.Vladimir Milushkin, Medsilica Group’s CEO, – “We believe, our Artificial Intelligent Robots will create many new jobs in New Zealand and Australia”.

The company’s plan is to launch this type of  machine in Australia at the end of this year.

The Medsilica-Promobot Artificial Intelligent Robots are used in many fields: Airports, Security , Banks, Universities, Insurance companies, Councils, Museums, etc.


Please rate this information
  • 5/5
  • 4 ratings
4 ratingsX
Very bad! Bad Hmmm Oke Good!
0% 0% 0% 0% 100%
Read More

ENTEROSGEL HAS BEEN TESTED BY ACCREDITED SPORTS ANTI-DOPING LABORATORY

Enterosgel, batch #L309170051, has been tested by the Britain National Measurement Laboratory and Designated Institute (LGC) for a wide range of substances banned by WADA (the World Anti Doping Agency) to provide the highest level of assurance that they are safer for athletes to use.

LGC is a World Class sports doping control and research laboratory, with more than 50 years of leadership in drug surveillance in sport.

Ryan Bellone | Business Development Manager | Sport and Specialized Analytical Services | Standards | Mobile: +1 206-452-4948 | ryan.bellone@lgcgroup.com | Skype: lgc.ryan.bellone |
LGC Lexington | 1745 Alysheba Way, Suite 160 | Lexington | Kentucky | 40509 | USA |
LGC Fordham | Newmarket Road | Fordham | Cambridgeshire | CB7 5WW | UK |
informed-choice.org | informed-sport.com | lgcgroup.com


Please rate this information
  • 5/5
  • 2 ratings
2 ratingsX
Very bad! Bad Hmmm Oke Good!
0% 0% 0% 0% 100%
Read More

Treatment with antibiotics must necessarily be accompanied by the prescription of enterosorbents.

 

New medical publication is available for professionals

Irrespective of the type of diarrhoea, probiotics, enterosorbents and medications of immunomodulatory action should be considered alternative to antibiotics and chemotherapeutic agents for starting etiotropic therapy of mild, moderate, even severe forms of Acute intestinal infections in children (under condition of starting treatment on day 1-2 of the disease).


Please rate this information
  • 5/5
  • 1 rating
1 ratingX
Very bad! Bad Hmmm Oke Good!
0% 0% 0% 0% 100%
Read More

ENTEROSGEL IS REGISTERED IN AUSTRALIA

Congratulation!

After 3 years debates, Department of Health and Therapeutic Goods approved to supply Enterosgel- Mineral-based gastrointestinal detoxifier to Australia.

Intended Use
Enterosgel is an intestinal absorbent (enterosorbent) intended to be used as an adjuvant to standard rehydration therapy and in the management and reduction of stomach and intestinal illness symptoms.


Please rate this information
  • 4.8/5
  • 4 ratings
4 ratingsX
Very bad! Bad Hmmm Oke Good!
0% 0% 0% 25% 75%
Read More

A new translation of Scientific Publication for Professionals is available.

ALLERGOLOGY AND DERMATOLOGY
Modern pediatrics 3 (37) / 2011

FORECASTING HEALTH STATUS OF CHILDREN WITH EARLIEST MANIFESTATIONS OF ATOPIC DERMATITIS

T.L. Protsyuk, N.I. Tocarchuk, L.A. Protsyuk, О. V. Chirkа, N.M. Surkovа, L.D. Kotsur
National Pirogov Memorial Medical University,  Vinnytsya Regional Children’s Clinical Hospital

MATERIAL AND METHODS OF THE STUDY
90 infants in the first year of life with severe (45 patients) and moderate (45 patients) atopic dermatitis (group 1) and 50 patients in the first year of life with mild forms of atopic dermatitis – (group 2) were examined. Follow-ups of children were carried out during 4 years.


Please rate this information
  • 5/5
  • 1 rating
1 ratingX
Very bad! Bad Hmmm Oke Good!
0% 0% 0% 0% 100%
Read More

THE SECRET OFFER

from Exclusive Distributor of Enterosgel in New Zealand & Australia

Please rate this information
  • 5/5
  • 2 ratings
2 ratingsX
Very bad! Bad Hmmm Oke Good!
0% 0% 0% 0% 100%
Read More